Skip to content
healthcare.dev

Hydromorphone Hydrochloride

NDC 0641-2341, Hydromorphone Hydrochloride, injection, from Hikma Pharmaceuticals USA Inc..

Product NDC
0641-2341
Status
Listed
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
INJECTION
Route
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0641-2341 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDROMORPHONE HYDROCHLORIDE2 mg/mL

Pharmacologic classes

Full Opioid Agonists [MoA]; Opioid Agonist [EPC]

Package NDCNDC-11Package
0641-2341-410064123414120 VIAL in 1 CARTON (0641-2341-41) / 20 mL in 1 VIAL (0641-2341-39)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b325028e-0722-4c8c-9fdb-ab6fb0dc460c
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0641-2341

Use it

Look up 0641-2341 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0641-2341 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0641-2341. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.